SCHEMBL4433495

SCHEMBL4433495

C=C(C(=O)O)c1ccc(C(F)(F)F)nc1CCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37
GABRG1 Q8N1C3 2/20 0.37
GABRG3 Q99928 2/20 0.37
GABRQ Q9UN88 2/20 0.37
TRPV1 Q8NER1 2/20 0.36
JUN P05412 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21496169 0.88 GABRP (0.36) NPC1RAB9AGABRPGABRDGABRA1
SCHEMBL3772717 0.81 TRPV1 (0.38) NPC1RAB9AGABRPGABRDGABRA1
SCHEMBL13018273 0.80 TRPV1 (0.37) NPC1RAB9AGABRPGABRDGABRA1
SCHEMBL3773277 0.80 NPC1 (0.39) NPC1RAB9ALMNASYKGAA
SCHEMBL28110449 0.79 TUBB4A (0.49) NPC1RAB9ATRPV1JUNNFKB1
SCHEMBL3778161 0.78 NR4A2 (0.41) NPC1RAB9AGABRPGABRDGABRA1
SCHEMBL3778165 0.78 NR4A2 (0.41) NPC1RAB9AGABRPGABRDGABRA1
SCHEMBL3778167 0.78 NR4A2 (0.41) NPC1RAB9AGABRPGABRDGABRA1
SCHEMBL3777929 0.76 PDPK1 (0.36) NPC1RAB9AGABRPGABRDGABRA1
SCHEMBL3777931 0.76 PDPK1 (0.36) NPC1RAB9AGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054411-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2009-05-06 EP disclosed
WO-2008013414-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2008-01-31 WO disclosed